华东地区苯二氮卓类药物及z类药物处方变化趋势(2015-2021年)

IF 1.3 Q3 PSYCHIATRY
Alpha psychiatry Pub Date : 2025-02-28 eCollection Date: 2025-02-01 DOI:10.31083/AP38792
Qian Deng, Hualiang Chen
{"title":"华东地区苯二氮卓类药物及z类药物处方变化趋势(2015-2021年)","authors":"Qian Deng, Hualiang Chen","doi":"10.31083/AP38792","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study analyses trends in the prescription and usage of benzodiazepines (BZDs) and Z-drugs within specialised medical institutions and emergency outpatient services in China from 2015 to 2021, focusing on demographics and prescribing patterns to promote better management practices.</p><p><strong>Methods: </strong>A retrospective study was conducted from 2015 to 2021, reviewing prescription information and population characteristics from 10 hospitals, including specialised psychiatric institutions and general hospitals in Zhejiang, Jiangsu, and Shanghai. The study analysed a total of 33,569 valid prescriptions.</p><p><strong>Results: </strong>There was a noticeable increase in the total defined daily doses of both benzodiazepines and Z-drugs, with significant variations among different drugs. Lorazepam and zopiclone showed the most substantial increases in usage. Drugs like clonazepam and lorazepam were predominantly prescribed, indicating specific patterns in disease management, particularly for insomnia and anxiety.</p><p><strong>Conclusions: </strong>This study reveals a significant increase in benzodiazepine and Z-drug prescriptions, particularly among elderly and female patients. The findings highlight the need for targeted interventions and policy reforms to ensure safe prescribing practices and mitigate the risks associated with long-term use in these vulnerable populations.</p>","PeriodicalId":72151,"journal":{"name":"Alpha psychiatry","volume":"26 1","pages":"38792"},"PeriodicalIF":1.3000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11916059/pdf/","citationCount":"0","resultStr":"{\"title\":\"Trends in Benzodiazepine and Z-Drug Prescriptions in Eastern China (2015-2021).\",\"authors\":\"Qian Deng, Hualiang Chen\",\"doi\":\"10.31083/AP38792\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study analyses trends in the prescription and usage of benzodiazepines (BZDs) and Z-drugs within specialised medical institutions and emergency outpatient services in China from 2015 to 2021, focusing on demographics and prescribing patterns to promote better management practices.</p><p><strong>Methods: </strong>A retrospective study was conducted from 2015 to 2021, reviewing prescription information and population characteristics from 10 hospitals, including specialised psychiatric institutions and general hospitals in Zhejiang, Jiangsu, and Shanghai. The study analysed a total of 33,569 valid prescriptions.</p><p><strong>Results: </strong>There was a noticeable increase in the total defined daily doses of both benzodiazepines and Z-drugs, with significant variations among different drugs. Lorazepam and zopiclone showed the most substantial increases in usage. Drugs like clonazepam and lorazepam were predominantly prescribed, indicating specific patterns in disease management, particularly for insomnia and anxiety.</p><p><strong>Conclusions: </strong>This study reveals a significant increase in benzodiazepine and Z-drug prescriptions, particularly among elderly and female patients. The findings highlight the need for targeted interventions and policy reforms to ensure safe prescribing practices and mitigate the risks associated with long-term use in these vulnerable populations.</p>\",\"PeriodicalId\":72151,\"journal\":{\"name\":\"Alpha psychiatry\",\"volume\":\"26 1\",\"pages\":\"38792\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2025-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11916059/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alpha psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31083/AP38792\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alpha psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31083/AP38792","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究分析2015 - 2021年中国专业医疗机构和急诊门诊苯二氮卓类药物(BZDs)和z类药物的处方和使用趋势,重点分析人口统计学和处方模式,以促进更好的管理实践。方法:对2015 - 2021年浙江、江苏、上海三地精神病专科医院、综合医院等10家医院的处方信息和人群特征进行回顾性研究。该研究共分析了33569张有效处方。结果:苯二氮卓类药物和z类药物的总限定日剂量均有显著增加,且不同药物之间存在显著差异。劳拉西泮和佐匹克隆的使用量增幅最大。氯硝西泮(clonazepam)和劳拉西泮(lorazepam)等药物主要是处方药,这表明了疾病管理的特定模式,尤其是失眠和焦虑。结论:本研究显示苯二氮卓类药物和z -药物处方明显增加,特别是在老年和女性患者中。研究结果强调需要有针对性的干预措施和政策改革,以确保这些弱势群体的处方做法安全,并减轻与长期使用相关的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Trends in Benzodiazepine and Z-Drug Prescriptions in Eastern China (2015-2021).

Objective: This study analyses trends in the prescription and usage of benzodiazepines (BZDs) and Z-drugs within specialised medical institutions and emergency outpatient services in China from 2015 to 2021, focusing on demographics and prescribing patterns to promote better management practices.

Methods: A retrospective study was conducted from 2015 to 2021, reviewing prescription information and population characteristics from 10 hospitals, including specialised psychiatric institutions and general hospitals in Zhejiang, Jiangsu, and Shanghai. The study analysed a total of 33,569 valid prescriptions.

Results: There was a noticeable increase in the total defined daily doses of both benzodiazepines and Z-drugs, with significant variations among different drugs. Lorazepam and zopiclone showed the most substantial increases in usage. Drugs like clonazepam and lorazepam were predominantly prescribed, indicating specific patterns in disease management, particularly for insomnia and anxiety.

Conclusions: This study reveals a significant increase in benzodiazepine and Z-drug prescriptions, particularly among elderly and female patients. The findings highlight the need for targeted interventions and policy reforms to ensure safe prescribing practices and mitigate the risks associated with long-term use in these vulnerable populations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信